Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Solium Capital closes US$23 million bought deal financing

Reading Time 1 minute read Subscribe



GMP Securities L.P.

On November 26, 2013, Solium Capital Inc. (Solium) completed a “bought deal” public offering for aggregate gross proceeds of $23,000,184, including the full exercise of the over-allotment option granted to the underwriters. The offering was conducted by a syndicate of underwriters co-led by GMP Securities L.P., Canaccord Genuity Corp., and Laurentian Bank Securities Inc. and including PI Financial Corp. and M Partners Inc. who purchased, on a “bought deal” basis, an aggregate of 3,565,920 common shares at a price of $6.45 per common share. The proceeds of the offering will be added to Solium’s working capital and applied to fund acquisitions and expansion. The underwriters were advised by a team from Fasken Martineau, including Rubin Rapuch, John Sabetti, Daniel Fuke and Justine Connelly (corporate/securities) and Mitchell Thaw (tax) with the assistance of students-at-law David Steinhauer and Corum Van Esch.



    Receive email updates from our team